Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Stock Charts To Watch: AMD Continues To Push Forward

Published 11/14/2019, 12:47 AM
Updated 07/09/2023, 06:31 AM

Advanced Micro Devices, Inc. (AMD)

Advanced Micro Devices Inc (NASDAQ:AMD) continues to push forward after breaking out in the low 30’s and I put a swing on it. On Wednesday, it popped 81 cents, or 2.21%, to 37.52, with a high of 37.96, on 67.4 million shares. My target was 39, 40, 44. When it went up to 37.96, it broke out of a little wedge, so the targets are now 40, 44, and then 48.

Amarin Corporation plc (AMRN)

Amarin Corporation PLC (NASDAQ:AMRN) is on the move after that big pop on Tuesday. It followed through on Wednesday, gaining 55 cents, or 2.63%, to 21.49, with a high of 22.05, on 23.5 million shares. I believe I am now looking for a test of the 23 1/2-24 zone, and then 26. Those are my targets going forward. You may get a pullback. Look for an entry opportunity.

Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) is spectacular. On Wednesday, it closed up another 3.23, or 7.15%, to 48.51, with a high of 48.87, on 2.5 million shares. This stock looks outstanding, but short-term it’s overbought. It has gone from under 6.00, to over 23 1/2 in just five weeks, and is at the top of the channel. It may accelerate, eventually, though, to be a 70-80-dollar stock.

Clovis Oncology, Inc. (CLVS)

Clovis Oncology Inc (NASDAQ:CLVS) is on the move, as well. After a 2-day run on low volume, it was up again on Wednesday, running 1.09, or 19.85%, to 6.55, with a high of 6.80, on 31.2 million shares. That’s the second biggest volume it has ever had that I can see. I think this stock is headed for 8 and then 9 1/2

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

CRISPR Therapeutics AG (CRSP)

Crispr Therapeutics AG (NASDAQ:CRSP) had a nice inside day of 1.42, or 2.65%, to 55.00, on Wednesday, with a high of 56.00, on a little over 1 million shares. I think it can go higher. If there is no wedge, Tuesday’s consolidation above resistance tells me we can go to 58, and then 64.

Inogen, Inc. (INGN)

Inogen Inc (NASDAQ:INGN) is in a perfect 5-6-day little, mini-wedge, and popped out on Wednesday, gaining 1.05, or 1.52%, to 70.10, with a high of 70.13, on 416,961 shares traded. If this extends at all, targets are 73 3/4, 78, 85 and 95, going forward.

SeaChange International, Inc. (SEAC)

SeaChange International Inc (NASDAQ:SEAC) is doing very well, and on Wednesday, it was up 32 cents, or 10.74%, to 3.30, with a high of 3.44, on nearly 1 million shares. After it popped, it formed a 2-month trading range, and did it with volume. I’m looking for an extension to 4-4 1/4, and eventually 5 1/2-6.

Stocks on the long side

Advanced Micro Devices, Inc. (NASDAQ:AMD), Amarin Corporation plc (AMRN), Arrowhead Pharmaceuticals, Inc. (ARWR), Antares Pharma, Inc. (ATRS), Cardlytics, Inc. (CDLX), Clovis Oncology, Inc. (CLVS), Constellation Pharmaceuticals, Inc. (CNST), CRISPR Therapeutics AG (CRSP), Covetrus, Inc. (CVET), Datadog, Inc. (DDOG), The Walt Disney Company (NYSE:DIS), Fastly, Inc. (FSLY), Infinera Corporation (INFN), Inogen, Inc. (INGN), Jounce Therapeutics, Inc. (JNCE), Luckin Coffee Inc. (LK), MACOM Technology Solutions (MTSI), comScore, Inc. (SCOR), SeaChange International, Inc. (SEAC), and Verso Corporation (VRS).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Watch video here...

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.